Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 551 of 1,261
  1. US 10039819

    Attenuated Mannheimia haemolytica strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  2. US 10039818

    Attenuated pasteurella multocida strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  3. US 10039816

    Siderophore-based immunization against gram-negative bacteria

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  4. US 10039908

    Swallowable drug delivery device and method of delivery

    Rani Therapeutics, LLC · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  5. US 10039775

    Preparation method for antitumor drug AP26113

    Suzhou Miracpharma Technology Co., Ltd. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  6. US 10039761

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  7. US 10040766

    Ubiquitination inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  8. US 10039738

    Ulcer treatment

    UNITED ARAB EMIRATES UNIVERSITY · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  9. US 10039827

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  10. US 10039807

    bFGF-polymer conjugates, methods for making the same and applications thereof

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  11. US 10041041

    Compositions and methods for treating retinal diseases

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  12. US 10039762

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  13. US 10039802

    Methods of treating chronic disorders with complement inhibitors

    Apellis Pharmaceuticals, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  14. US 10040769

    HDAC inhibitors for the treatment of diabetic peripheral neuropathy

    Regenacy Pharmaceuticals, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  15. US 10041936

    Neuronal cells cultured on microparticles and methods of using same

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  16. US 10035824

    Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

    Protagonist Therapeutics, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  17. US 10035981

    Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

    The Regents of the University of California · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  18. US 10034863

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  19. US 10035823

    Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions

    The Regents of the University of California · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  20. IL 259901

    Functionalized macrocycle chelators, complexes containing same and uses thereof as contrast agents

    BRACCO IMAGING SPA [IT] · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  21. US 10034936

    Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  22. US 10035848

    Antibody targeting cell surface deposited complement protein C3d and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  23. US 10034893

    5, 6-D2 uridine nucleoside/tide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  24. US 10036020

    Compositions and methods for inhibiting JC virus (JCV)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.